The incidence of esophageal adenocarcinoma (EAC) has increased in many Western
countries and is higher in men than women. Some risk factors for EAC have been identified …

Oesophageal cancer is a clinically challenging disease that requires a multidisciplinary
approach. Extensive treatment might be associated with a considerable decline in health …

Background Neoadjuvant therapy improves long-term survival after oesophagectomy,
treating oesophageal cancer, but the evidence to date is insufficient to determine which of …

Background Targeting PLK1 has recently been proven as a viable therapeutic strategy
against oesophageal squamous cell carcinom (ESCC). Therefore, this study aimed to …

Esophageal adenocarcinomas are associated with a dismal prognosis. Deciphering the
evolutionary history of this disease may shed light on therapeutically tractable targets and …

Background There is increasing evidence for the use of exercise in cancer patients and data
supporting enhanced tumour volume reduction following chemotherapy in animal models …

Esophageal adenocarcinoma (EAC) is a deadly cancer with high mortality rate, especially in
economically advanced countries, while Barrett's esophagus (BE) is reported to be a …

Background This multicentre cohort study sought to define a robust pathological indicator of
clinically meaningful response to neoadjuvant chemotherapy in oesophageal …

Importance The prognostic role of the extent of lymphadenectomy during surgery for
esophageal cancer is uncertain and requires clarification. Objective To clarify whether the …

Natural types of cells display distinct characteristics with homotypic targeting and extended
circulation in the blood, which are worthy of being explored as promising drug delivery …